Challenges and advances of the stability of mRNA delivery therapeutics
Jin Zhai, Trystin Cote, Yupeng Chen
13 March 2024
Expert Insight
Next-generation DNA vectors: is the nS/MARt platform a viable alternative to viruses for autologous T-cell immunotherapy?
Matthias Bozza, Richard Harbottle
23 November 2021
Expert Insight